<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e> (BD) is a <z:hpo ids='HP_0011010'>chronic</z:hpo> systemic <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Inflammatory reactions trigger the <z:mp ids='MP_0003674'>oxidative stress</z:mp> and oxidants decrease the level of <z:chebi fb="11" ids="22586">antioxidants</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, we aimed to determine serum oxidative/antioxidative status in patients with BD </plain></SENT>
<SENT sid="3" pm="."><plain>Serum antioxidative status was evaluated by measuring total <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity (<z:chebi fb="44" ids="53498">TAC</z:chebi>), paraoxonase 1, arylesterase, sulfhydryl groups and ceruloplasmin in patients with BD and in healthy controls </plain></SENT>
<SENT sid="4" pm="."><plain>Serum oxidative status was evaluated by measuring total <z:chebi fb="39" ids="44785">peroxide</z:chebi> (TP), <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:chebi fb="0" ids="35923,35924">hydroperoxides</z:chebi> and <z:mp ids='MP_0003674'>oxidative stress</z:mp> index (OSI) </plain></SENT>
<SENT sid="5" pm="."><plain>OSI was calculated by percent ratio of TP to <z:chebi fb="44" ids="53498">TAC</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Serum levels of <z:chebi fb="44" ids="53498">TAC</z:chebi>, sulfhydryl groups and activities of paraoxonase 1, arylesterase, and ceruloplasmin were significantly lower in patients than in controls (p &lt; 0.001 for <z:hpo ids='HP_0000001'>all</z:hpo>) </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, TP, <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:chebi fb="0" ids="35923,35924">hydroperoxides</z:chebi> and OSI values were significantly higher in patients than in controls (p &lt; 0.001 for <z:hpo ids='HP_0000001'>all</z:hpo>) </plain></SENT>
<SENT sid="8" pm="."><plain>Further, the level of <z:chebi fb="44" ids="53498">TAC</z:chebi> was negatively correlated with the levels of TP, <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:chebi fb="0" ids="35923,35924">hydroperoxides</z:chebi> and OSI both in the BD (r = -0.578, p &lt; 0.01; r = -0.559, p &lt; 0.01 and r = -0.552, p &lt; 0.01, respectively) and the control groups (r = -0.469, p &lt; 0.05; r = -0.351, p &lt; 0.05 and r = -0.391, p &lt; 0.05, respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>These results indicate that the oxidant parameters increased and <z:chebi fb="11" ids="22586">antioxidant</z:chebi> parameters decreased in patients with BD; therefore, these patients might have been exposed to <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>We suggest that impaired oxidant/<z:chebi fb="11" ids="22586">antioxidant</z:chebi> balance should be taken into consideration in the follow-up of patients with BD </plain></SENT>
</text></document>